Clinical Trial Update: Immunoadsorption vs. Sham Treatment in Post COVID-19 Patients With Chronic Fatigue Syndrome [NA]

View source ↗

Summary

The clinical trial evaluating immunoadsorption versus sham treatment in post-COVID-19 patients with chronic fatigue syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Hannover Medical School | Conditions: Fatigue, Post-Acute COVID-19 Syndrome | NA | Status: COMPLETED